During the past decade, Shafran Gastroenterology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shafran Gastroenterology" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Shafran Gastroenterology" are "Ulcerative Colitis" (2 trials), "Distal Ulcerative Colitis" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "Left-sided Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Shafran Gastroenterology" in a lesser frequency.

Most popular intervention types in "Shafran Gastroenterology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Mesalamine Enema" (1 trials), "Methotrexate" (1 trials), "Rifaximin" (1 trials) and "Zoenasa-1:4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shafran Gastroenterology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Shafran Gastroenterology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Shafran Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shafran Gastroenterology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".